Saimir Luli

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie, John B. G. Mackey, Thomas Jamieson et al. · Gut · 2022 · 228 citations · Full text

Medicine, Immunology, Oncology +17

NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma

Caroline Wilson, Diana Jurk, Nicola Fullard et al. · Nature Communications · 2015 · 177 citations · Full text

Medicine, Molecular Biology, Oncology +17

FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis

Jack Leslie, Ben Millar, Alicia del Carpio Pons et al. · JCI Insight · 2020 · 102 citations · Full text

Life Sciences, Immunology, Pathology +15

A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A

Müjdat Zeybel, Saimir Luli, Laura Sabater et al. · Molecular Therapy · 2017 · 83 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling

Simon Tual‐Chalot, Maria Garcia-Collado, Rachael E. Redgrave et al. · Circulation Research · 2019 · 69 citations · Full text

Medicine, Molecular Genetics, Molecular Medicine +17